{
    "clinical_study": {
        "@rank": "1395", 
        "arm_group": [
            {
                "arm_group_label": "Exercise training", 
                "arm_group_type": "Experimental", 
                "description": "Cognitive Behavioural Therapy (CBT)\n+ Exercise training 3 times/week, 30 minutes on a treadmill, 70% maximal oxygen uptake (VO2max), 8 weeks"
            }, 
            {
                "arm_group_label": "Movements", 
                "arm_group_type": "Active Comparator", 
                "description": "Cognitive Behavioural Therapy (CBT)\n+ Low intensity physical activity without cardiovascular activation, 3 times/week, 30 minutes, 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Physical activity (treadmill) supports the effect of cognitive behavioural therapy in\n      patients with panic disorder with/without agoraphobia"
        }, 
        "brief_title": "Physical Activity and Cognitive Behavioural Therapy in Panic Disorder", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Panic Disorder", 
        "condition_browse": {
            "mesh_term": "Panic Disorder"
        }, 
        "detailed_description": {
            "textblock": "Patients undergo cognitive behavioural therapy consisting of 8 group sessions within 1\n      month. All patients additionally complete a training of physical activity, which starts\n      simultaneously to therapy and runs for 8 weeks (3 times/week, 30 minutes each). Half of the\n      patients complete training on a treadmill while the other half completes a training\n      programme of low intensity physical activity without cardiovascular activation.\n\n      Flanking EEG (electroencephalogram) recordings shall help clarify biological processes\n      underlying the therapeutical process."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject familiarized with experimental procedure and had given written informed\n             consent\n\n          2. Diagnosis of panic disorder with or without agoraphobia according to Diagnostic and\n             Statistical Manual of Mental Disorders (DSM-IV)\n\n          3. Sufficiently able to communicate with investigator, answer questions and fill in\n             questionnaires\n\n          4. Reachability of patient for treatment and follow-up\n\n        Exclusion Criteria:\n\n          1. Other psychiatric illnesses like schizophrenia, substance abuse or  severe depressive\n             episode\n\n          2. Acute suicidal tendency\n\n          3. Epilepsy or other illness of the central nervous system (e.g. brain tumor,\n             encephalitis)\n\n          4. Existence of contraindication against physical exercise\n\n          5. Pregnancy or breastfeeding\n\n          6. Changes of psychopharmacological treatment within the last 4 weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "46", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788800", 
            "org_study_id": "221012"
        }, 
        "intervention": {
            "arm_group_label": [
                "Exercise training", 
                "Movements"
            ], 
            "description": "9 sessions of CBT including psychoeducation and interoceptive exposure", 
            "intervention_name": "Cognitive Behavioural Therapy (CBT)", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Panic disorder", 
            "Physical activity"
        ], 
        "lastchanged_date": "May 15, 2013", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.angstambulanz-charite.de"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Influence of Physical Activity on the Effect of Cognitive Behavioural Therapy, Neurobiological Parameters and Information Processing in Patients With Panic Disorder With/Without Agoraphobia", 
        "other_outcome": {
            "description": "EEG (Mismatch Negativity, Loudness dependency, P50/P300) and diurnal profile of Cortisol and alpha-Amylase", 
            "measure": "EEG and endocrinology", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)"
        }, 
        "overall_official": {
            "affiliation": "Department of Psychiatry and Psychotherapy, CCM, Charit\u00e9 - Universit\u00e4tsmedizin Berlin", 
            "last_name": "Andreas Str\u00f6hle, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Global interviewer rated measure for anxiety and severity indicator of an anxiety disorder", 
            "measure": "Hamilton Rating Scale for Anxiety (CIPS 1995)", 
            "safety_issue": "No", 
            "time_frame": "up to  28 weeks (follow up)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788800"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Charite University, Berlin, Germany", 
            "investigator_full_name": "Prof. Dr. Andreas Str\u00f6hle", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Panic and Agoraphobia Scale (Bandelow et al. 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)"
            }, 
            {
                "measure": "Beck Anxiety Inventory (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)"
            }, 
            {
                "measure": "Clinical Global Index (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)"
            }, 
            {
                "measure": "Beck Depression Inventory (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)"
            }
        ], 
        "source": "Charite University, Berlin, Germany", 
        "sponsors": {
            "collaborator": {
                "agency": "German Federal Ministry of Education and Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Charite University, Berlin, Germany", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}